Correction: PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial. [ISCRTN74418480]

BACKGROUND: The Paracetamol (Acetaminophen) In Stroke (PAIS) study is a phase III multicenter, double blind, randomized, placebo-controlled clinical trial of high-dose acetaminophen in patients with acute stroke. The trial compares treatment with a daily dose of 6 g acetaminophen, started within 12...

Descripción completa

Detalles Bibliográficos
Autores principales: den Hertog, Heleen M, Worp, H Bart van der, van Gemert, H Maarten A, Algra, Ale, Kappelle, L Jaap, van Gijn, Jan, Koudstaal, Peter J, Dippel, Diederik WJ
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600816/
https://www.ncbi.nlm.nih.gov/pubmed/18983661
http://dx.doi.org/10.1186/1471-2261-8-29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600816/
https://www.ncbi.nlm.nih.gov/pubmed/18983661
http://dx.doi.org/10.1186/1471-2261-8-29

Ejemplares similares